Team

There is much to do, and every day is precious!   Over the last weeks, we have seen a remarkable outpouring of support and volunteers that want to help see this ambitious vision come to fruition, and be a part of turning the tide and winning the war on Covid-19.   This gives us the courage and conviction to plunge forward.  It’s a leap of faith, based on the belief that when people are empowered with the right tools, a clear plan of action, and the ability to help themselves and each other, that anything is possible.

If you are someone that can help, please join us!

Geoff Halstead

Fractional CPO, Digital product strategist and builder.  Geoff turns ideas into action.

Allison Hemming

Digital Guru, Talent Recruiter and Center of Action.  Allison makes things happen.

R. Scott Hanson, MD, MPH, FACP

Dr. Hanson is an experienced Physician with a demonstrated history of working in public and private healthcare systems. Skilled in Internal Medicine including MAT for Opioid Use Disorder, Urgent Care, Public Health and Medical Education, he graduated from Tulane University School of Medicine and Yale, and received clinical training at Bethesda Naval Medical Center and RI Hospital/Brown University. Dr. Hanson is currently a physician with the Veterans Administration in Maine, serves on the board of the Maine Medical Association and is active in multiple public health initiatives.

Jason Ciment

CEO, Author, Speaker, Digital Marketing Guru for SEO, PPC and Social Media.  Jason’s team built and manages the Web site and supports the social media campaigns.

James C. Roberts III, Esq.

Managing Principle, Global Capital Law, LLC.  Strategic & legal counsel for innovative tech and social enterprise for clients in North America, the European Union and Asia.

Science Advisors

Immunoprevention.org was founded on the vision and understanding of Dr. Scott Halstead of the crucial role that antibodies could play in saving lives and safely re-opening the economy more rapidly from the COVID-19 Epidemic.   In the early days of the epidemic, Dr. Halstead began writing science papers analyzing the risk of Antibody Dependent Enhancement (ADE) in the SARS-COV2 virus (COVID 19 Vaccines: Should we fear ADE?), and calling for urgent action to scale the production of antibody-based therapeutics (COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase).

Dr. Halstead and Dr. Ramesh Akkina are advisors to Immunoprevention.org on matters related to virology, vaccinology and epidemiology.

Scott B Halstead, MD

Dr. Scott Halstead is an American physician-scientist, virologist, and epidemiologist known for his work in the fields of tropical medicine and vaccine development.  He is a world leading authority on viruses transmitted by mosquitoes, including dengue, Japanese encephalitis, chikungunya, and Zika, and one of the first researchers to identify the phenomenon known as antibody-dependent enhancement (ADE), where the antibodies generated from a first dengue infection can sometimes worsen the symptoms from a second infection.  Halstead is widely published, having authored and contributed to over 400 scientific papers and 112 book chapters covering topics ranging from vaccines, mosquito-borne infectious diseases, to international public health and education. In 1990, as a Director at the Rockefeller Foundation, Halstead co-founded the Children’s Vaccine Initiative, now known as The GAVI Alliance and lead and funded the formation of the International Clinical Epidemiology Network (INCLEN).  In 2003, he founded the Pediatric Dengue Vaccine Initiative with $55M from the Gates Foundation.

Professor Ramesh Akkina, PhD

Dr. Ramesh Akkina is Professor of Microbiology, Immunology, and Pathology at Colorado State University, Fort Collins, CO. He was also a visiting professor at the UCLA School of Medicine, Los Angeles. His early contributions were in Influenza virology and stem-cell based gene therapy strategies. He pioneered in research work using vivo models for HIV, Dengue and Zika viruses. His lab tested pre-exposure prophylaxis methods to prevent HIV transmission, evaluated novel anti-HIV RNA compounds, showed that immune exhaustion during HIV infection can be partially reversed and developed an ultra-sensitive test to detect latent HIV. He is a member of many editorial and international grant review boards. He currently serves as the Center Director for Global Virus Network, an international organization of prominent virologists around the world involved in addressing the constantly evolving and newly emerging viruses.

Scroll to top